Skip to main content
Christopher Clark, MD, Physical Medicine/Rehab, Hagerstown, MD

ChristopherDavidClarkMD

Physical Medicine/Rehab Hagerstown, MD

Pain Medicine, Sports Medicine (Non-Surgical)

Pain Management, Sports Medicine. Premier Spine and Sports Medicine

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clark's full profile

Already have an account?

  • Office

    13114 Pennsylvania Ave
    Hagerstown, MD 21742
    Phone+1 301-800-7770
    Fax+1 301-800-7891

Education & Training

  • Performance Spine & Sports Medicine
    Performance Spine & Sports MedicineFellowship, Pain Medicine, 2014 - 2015
  • Sinai Hospital of Baltimore
    Sinai Hospital of BaltimoreResidency, Physical Medicine and Rehabilitation, 2011 - 2014
  • ECU Health Medical Center/East Carolina University
    ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 2010 - 2011
  • Brody School of Medicine at East Carolina University
    Brody School of Medicine at East Carolina UniversityClass of 2010

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2016 - 2026
  • PA State Medical License
    PA State Medical License 2014 - 2024
  • NJ State Medical License
    NJ State Medical License 2014 - 2019
  • NC State Medical License
    NC State Medical License 2010 - 2011
  • American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation

Press Mentions

  • Idorsia Pharmaceuticals Announces Support for a Clinical Trial Being Conducted by the U.S. Department of Defense Evaluating QUVIVIQ (Daridorexant) as Potential Therapy for Treatment of Posttraumatic Stress Disorder (PTSD)
    Idorsia Pharmaceuticals Announces Support for a Clinical Trial Being Conducted by the U.S. Department of Defense Evaluating QUVIVIQ (Daridorexant) as Potential Therapy for Treatment of Posttraumatic Stress Disorder (PTSD)May 10th, 2023

Professional Memberships